新晨科技(300542.SZ):實控人李福華解除質押749.5998萬股
格隆匯12月2日丨新晨科技(300542.SZ)公佈,公司近日接到公司控股股東、實際控制人李福華的通知,獲悉李福華將其所持有公司的部分被質押股份已全部解除質押,解除質押股數749.5998萬股。
截至公告披露日,李福華持有公司股份3353.25萬股,佔公司總股本的14.47%。李福華於2019年11月29日辦理了部分股份解除質押手續,解除質押股份合計749.5998萬股,佔其持有公司股份總數的22.35%,佔公司總股本的3.23%。此次解除質押完成後,李福華所持有公司股份中仍處於質押狀態的股份數量為0股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.